BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32736640)

  • 1. Increasing prevalence of anticholinergic medication use in older people in England over 20 years: cognitive function and ageing study I and II.
    Grossi CM; Richardson K; Savva GM; Fox C; Arthur A; Loke YK; Steel N; Brayne C; Matthews FE; Robinson L; Myint PK; Maidment ID
    BMC Geriatr; 2020 Jul; 20(1):267. PubMed ID: 32736640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study.
    Fox C; Richardson K; Maidment ID; Savva GM; Matthews FE; Smithard D; Coulton S; Katona C; Boustani MA; Brayne C
    J Am Geriatr Soc; 2011 Aug; 59(8):1477-83. PubMed ID: 21707557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.
    Campbell NL; Perkins AJ; Bradt P; Perk S; Wielage RC; Boustani MA; Ng DB
    Pharmacotherapy; 2016 Nov; 36(11):1123-1131. PubMed ID: 27711982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
    Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
    Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison over 2 decades of disability-free life expectancy at age 65 years for those with long-term conditions in England: Analysis of the 2 longitudinal Cognitive Function and Ageing Studies.
    Bennett HQ; Kingston A; Lourida I; Robinson L; Corner L; Brayne C; Matthews FE; Jagger C;
    PLoS Med; 2022 Mar; 19(3):e1003936. PubMed ID: 35290368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
    Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
    J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
    Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
    Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinergic medication burden and cognitive function in participants of the ASPREE study.
    Broder JC; Ryan J; Shah RC; Lockery JE; Orchard SG; Gilmartin-Thomas JF; Fravel MA; Owen AJ; Woods RL; Wolfe R; Storey E; Murray AM; Ernst ME
    Pharmacotherapy; 2022 Feb; 42(2):134-144. PubMed ID: 34866212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergic Burden and Functional Status in Older People with Cognitive Impairment: Results from the Regal Project.
    Boccardi V; Baroni M; Paolacci L; Ercolani S; Longo A; Giordano M; Ruggiero C; Mecocci P
    J Nutr Health Aging; 2017; 21(4):389-396. PubMed ID: 28346565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
    Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.
    Dauphinot V; Mouchoux C; Veillard S; Delphin-Combe F; Krolak-Salmon P
    Alzheimers Res Ther; 2017 Aug; 9(1):58. PubMed ID: 28764796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis.
    Pieper NT; Grossi CM; Chan WY; Loke YK; Savva GM; Haroulis C; Steel N; Fox C; Maidment ID; Arthur AJ; Myint PK; Smith TO; Robinson L; Matthews FE; Brayne C; Richardson K
    Age Ageing; 2020 Oct; 49(6):939-947. PubMed ID: 32603415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
    Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
    Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia.
    Cross AJ; George J; Woodward MC; Ames D; Brodaty H; Ilomäki J; Elliott RA
    Drugs Aging; 2016 Jan; 33(1):37-44. PubMed ID: 26645294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Anticholinergic Drug Burden With Cognitive and Functional Decline Over Time in Dementia With Lewy Bodies: 1-Year Follow-Up Study.
    Ozsurekci C; Satis NK; Demircan SK; Naharci MI
    Clin Neuropharmacol; 2024 Mar-Apr 01; 47(2):48-53. PubMed ID: 38478365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II.
    Matthews FE; Arthur A; Barnes LE; Bond J; Jagger C; Robinson L; Brayne C;
    Lancet; 2013 Oct; 382(9902):1405-12. PubMed ID: 23871492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.
    Cross AJ; George J; Woodward MC; Ames D; Brodaty H; Wolfe R; Connors MH; Elliott RA
    J Alzheimers Dis; 2017; 60(2):349-358. PubMed ID: 28869467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study.
    Grossi CM; Richardson K; Fox C; Maidment I; Steel N; Loke YK; Arthur A; Myint PK; Campbell N; Boustani M; Robinson L; Brayne C; Matthews FE; Savva GM
    BMC Geriatr; 2019 Oct; 19(1):276. PubMed ID: 31638906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholinergic Burden of Geriatric Ward Inpatients.
    Wilczyński K; Gorczyca M; Gołębiowska J; Szewieczek J
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684152
    [No Abstract]   [Full Text] [Related]  

  • 20. The extent of anticholinergic burden across an older Welsh population living with frailty: cross-sectional analysis of general practice records.
    Cheong VL; Mehdizadeh D; Todd OM; Gardner P; Zaman H; Clegg A; Alldred DP; Faisal M
    Age Ageing; 2023 Jul; 52(7):. PubMed ID: 37505992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.